Conclusion
AF monitoring following ablation is an indispensable tool to guide patient management. The traditional strategy of intermittent external ambulatory monitoring devices to assess recurrence of AF as a binary outcome is increasingly being recognized as inaccurate and misses the opportunity for tailored patient management. AF burden and duration assessment by personal monitoring devices, in the form of direct to consumer smart watches and smart phones, holds promise to guide individual patient management and is likely to empower patients to manage their own disease.